imatinib alkaloid-int 400 mg
synthon hispania s.l. - spania - imatinibum - compr. film. - 400mg - alte antineoplazice inhibitori de protein-kinaza
imatinib aurobindo 100 mg
polisano pharmaceuticals s.a. - romania - imatinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza
imatinib aurobindo 400 mg
polisano pharmaceuticals s.a. - romania - imatinibum - compr. film. - 400mg - alte antineoplazice inhibitori de protein-kinaza
imatinib grindeks 100 mg
as grindeks - letonia - imatinibum - caps. - 100mg - inhibitori de protein-kinaza
oxaliplatin accord 5 mg ml 200 mg/40 ml concentrat pentru soluţie perfuzabilă
accord healthcare polska sp. z o.o. - oxaliplatinum - concentrat pentru soluţie perfuzabilă - 200 mg/40 ml
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leucemie mieloidă - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.